Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Honghua Injection
- Development stage
- Phase 4
- Lead developer
- Shanxi Zhendong Ante Biopharmaceutical
- Modality
- Classical Binding Small Molecules → Small Molecules
- Administration
- Intravenous, Intramuscular
01
Overview
Honghua Injection (Safflower Injection) is a Traditional Chinese Medicine (TCM) parenteral therapy derived from the water extract of *Carthamus tinctorius L.* (safflower). Developed and marketed by Zhendong Anxin, it is primarily indicated for the treatment of cardiovascular and cerebrovascular diseases, including coronary heart disease, angina pectoris, cerebral infarction, and cerebral circulation insufficiency. Its pharmacological profile involves promoting blood circulation, resolving blood stasis, improving microcirculation, and exerting anti-myocardial ischemic and anticoagulant effects. The injection contains a complex mixture of bioactive compounds, notably flavonoids such as quinochalcones (e.g., hydroxysafflor yellow A), which contribute to its multi-target therapeutic action by reducing blood viscosity and inducing vasodilation.
- Other names
- Safflower Injection红花注射液
02
Targets
AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)ESR1 (ERα)HIF1A (Hypoxia-inducible factor 1-alpha)MMP9 (Matrix metalloproteinase-9)PIK3CA (Phosphoinositide 3-kinase alpha)PGHS-1 (Prostaglandin G/H Synthase 1)VEGFA (Vascular endothelial growth factor A)
Beyond the preview
Go deeper on Honghua Injection.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Honghua Injection.